NCT00222261View on ClinicalTrials.gov

Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.

PHASE4CompletedINTERVENTIONAL
Enrollment

1,001

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Coronary Heart DiseaseAngina PectorisAtherosclerosis
Interventions
DRUG

aspirin

Aspirin 160 mg once daily for two years

DRUG

clopidogrel

clopidogrel 75 mg once daily for two years

Trial Locations (1)

0407

Ullevaal University Hospital, Oslo

All Listed Sponsors
collaborator

The Norwegian Council for Cardiovascular Diseases.

UNKNOWN

collaborator

Ada and Hagbart Waages Humanitarian and Charity Foundation

OTHER

collaborator

Alf and Aagot Helgesens Research Foundation.

UNKNOWN

lead

Ullevaal University Hospital

OTHER

NCT00222261 - Aspirin Non-responsiveness and Clopidogrel Endpoint Trial. | Biotech Hunter | Biotech Hunter